ESS-1

Cat.No.: CSC-C0490

Species: Human

Source: endometrial stromal sarcoma

Morphology: adherent cells growing in monolayers, in some regions in multilayers

Inquire for Price

Specification
Q & A
Customer Review

Cat.No.

CSC-C0490

Description

Established from an endometrial stromal sarcoma of the uterus of a 76-year-old Caucasian woman; cells were described as demonstrating a mainly mesenchymal phenotype with signs of epithelial characteristics within foci and an extensively multilayered growth pattern

Species

Human

Source

endometrial stromal sarcoma

Recommended Medium

80% RPMI-1640 + 20% h.i. FBS

Morphology

adherent cells growing in monolayers, in some regions in multilayers

Karyotype

Human karyotype with hyper-diploid/tetraploid and -octaploid clones present in approx. equal numbers - 47(45-47)<2n>XX, +19, der(3)t(3;6)(q2?8;p11-12), add(6)(q27), add(19)(p11) - sideline with i(2q) - resembles published karyotype

Quality Control

Mycoplasma: negative in microbiological culture, RNA hybridization, PCR assays
Immunology: cytokeratin +, cytokeratin-7 (+), cytokeratin-8 -, cytokeratin-17 (+), cytokeratin-18 +, cytokeratin-19 -, desmin -, endothel -, EpCAM -, neurofilament -, vimentin

Storage and Shipping

Frozen with 70% medium, 20% FBS, 10% DMSO at about 1.5 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen

Citation Guidance

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Are cell viability assays restricted to specific cell types?

No, cell viability assays can be used with various cell types, including mammalian cells, microbial cells, and plant cells, allowing researchers to study different biological systems.

Ask a Question

Average Rating: 5.0 | 1 Scientist has reviewed this product

Invaluable

The retinoblastoma cells we obtained from Creative Bioarray have been highly valuable in our studies on treatment resistance mechanisms. Their behavior closely mimics the clinical scenario, allowing us to identify novel approaches to overcome drug resistance.

09 Dec 2022

Ease of use
After sales services
Value for money

Write your own review

You May Also Need

CM-1448Y

SuperCult® RPMI 1640 Medium

INQUIRY

CS-001Y

PremSera® FBS

INQUIRY

H-EMC-SS

Description: Species: human;
Tumor: chondrosarcoma

Cat#: CSC-6258W INQUIRY

View Product

Hs913T

Description: Species: human, Caucasian male 51 years old;
Tumor: fibrosarcoma;
Derived from: metastasis to lung

Cat#: CSC-6266W INQUIRY

View Product

TE671 Subline No.2

Description: Species: human, Caucasian female 6 years old;
Tumor: rhabdomyosarcoma;
Derived from: TE671 (described as medulloblastoma, then confirmed as rhabdomyosarcoma, probably identical to RD).

Cat#: CSC-6318W INQUIRY

View Product

CAL-72

Description: Established from a chemotherapy-resistant tumor sample obtained from the left knee of a 10-year-old boy with anaplastic osteoblastic sarcoma (Rosen grade IIB) in 1989

Cat#: CSC-C0473 INQUIRY

View Product

CAL-78

Description: Established from the recurrence of a dedifferentiated chondrosarcoma (grade III) of the muscle of the thigh from a 76-year-old man in 1989; tumorigenic chondrosarcomatous differentiation of xenografted tumor

Cat#: CSC-C0481 INQUIRY

View Product

RH-30

Description: Established from the bone marrow metastasis of a 17-year-old man with undifferentiated (standard classification) or unclassified (Palmer classification) alveolar rhabdomyosarcoma; cells were described as carrying a p53 mutation, expressing high levels of both myogenin and myoD, and expressing the Pax3/FKHR fusion protein secondary to the t(2;13)(q35;q14) translocation

Cat#: CSC-C0500 INQUIRY

View Product

For research use only. Not for any other purpose.